Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Fast Moving Fronts Comments

Return to menu of Fast Moving Fronts

ESI Special Topics, May 2004
Citing URL: http://www.esi-topics.com/fmf/2004/may04-BrianGSpratt.html

From •>>May 2004

Brian G. Spratt answers a few questions about this month's fast moving front in the field of Microbiology.

Field: Microbiology
Article: Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus
Authors: Enright, MC;Day, NPJ;Davies, CE;Peacock, SJ;Spratt, BG
Journal: J CLIN MICROBIOL, 38: (3) 1008-1015, MAR 2000
Addresses: Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, S Parks Rd, Oxford OX1 3FY, England.
Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England.
Univ Oxford, John Radcliffe Hosp, Nuffield Dept Pathol & Bacteriol, Oxford OX3 9DU, England.
Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Wellcome Trust Ctr Clin Trop Med, Oxford OX3 9DU, England.
for Microbiology.


ST:  Why do you think your paper is highly cited?

Mark Enright
Left to right: Karen McGregor, William Hanage, Brian Spratt, Nicole Bilek, Emma Meats, David Aanensen, Daniel Godoy
...there was the major concern about MRSA, and of the emergence of strains resistant to vancomycin”

There is great concern about infections with methicillin-resistant Staphylococcus aureus (MRSA) in hospitals, their emergence in the community setting, and the spectrum of variants that also are resistant to vancomycin. Understanding the spread of MRSA requires adequate ways of distinguishing the many different strains and this paper introduced a novel, unambiguous way of characterizing Staphylococcus aureus strains.

ST:  Does it describe a new discovery or a new methodology that’s useful to others?

Multilocus sequence typing (MLST) had recently been introduced as a precise way of characterizing isolates of bacterial pathogens and this paper developed this approach for S. aureus.

ST:  How did you become involved in this research?

We had developed MLST with our collaborators in 1998 and were keen to promote this sequence-based approach to strain characterization to other major bacterial pathogens. Mark Enright in my lab was developing MLST schemes for a number of pathogens and S. aureus was an obvious one—as it causes serious disease—and there was the major concern about MRSA, and of the emergence of strains resistant to vancomycin. We were dismayed by the fact that the methods of characterizing MRSA that were being used did not allow different laboratories to easily compare their strains. People in different countries were giving local names to the MRSA strains causing problems in their hospitals, and it was very unclear which strains were the same, and which were different. We decided to try and sort this out using MLST.

ST:  Could you summarize the significance of your paper in layman's terms?

Just as individual humans can be distinguished using fingerprinting, so the many different strains of a typical bacterial pathogen can be distinguished using appropriate methods. Ideally, these methods should be unambiguous and should allow strains characterized in different countries to be compared easily via the internet. The MLST technique we introduced for characterizing the important strains of Staphylococcus aureus—particularly the antibiotic-resistant MRSA strains that cause so many infections in hospitals—allows strains to be characterized unambiguously, which facilitates studies of their spread within and between hospitals, and also internationally.End

Professor Brian G. Spratt FRS 
Department of Infectious Disease Epidemiology 
Faculty of Medicine
Imperial College London
St. Mary's Hospital
London, U.K.

Mark C. Enright
Senior Research Fellow
University of Bath
Department of Biology & Biochemistry
Bath, U.K.

for Microbiology.

Return to Fast Moving Fronts | Return to Special Topics main menu
 

ESI Special Topics, May 2004
Citing URL: http://www.esi-topics.com/fmf/2004/may04-BrianGSpratt.html

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.